THERAGENICS CORP (TGX) financial statements (2021 and earlier)

Company profile

Business Address 5203 BRISTOL INDUSTRIAL WAY
BUFORD, GA 30518
State of Incorp. DE
Fiscal Year End December 31
SIC 3825 - Instruments for Measuring and Testing of Electricity and Electrical Signals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3734 
Cash and cash equivalents1716 
Short-term investments2018 
Receivables1010 
Inventory, net of allowances, customer advances and progress billings1516
Inventory1516 
Prepaid expense and other current assets1 
Other undisclosed current assets21 
Total current assets:6462 
Noncurrent Assets
Property, plant and equipment3232 
Intangible assets, net (including goodwill)910
Intangible assets, net (excluding goodwill)910 
Other noncurrent assets0 
Prepaid expense and other noncurrent assets0 
Other undisclosed noncurrent assets11 
Total noncurrent assets:4343 
TOTAL ASSETS:107105 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities44 
Accounts payable22 
Employee-related liabilities22 
Taxes payable00 
Other liabilities21 
Total current liabilities:65 
Noncurrent Liabilities
Long-term debt and lease obligation2222 
Long-term debt, excluding current maturities2222 
Liabilities, other than long-term debt11 
Asset retirement obligations11 
Other liabilities00 
Total noncurrent liabilities:2323 
Total liabilities:2928 
Stockholders' equity
Stockholders' equity attributable to parent7877 
Common stock00 
Treasury stock, value(10)(10) 
Additional paid in capital7676 
Accumulated other comprehensive income (loss)(0)0 
Retained earnings1111 
Total stockholders' equity:7877 
TOTAL LIABILITIES AND EQUITY:107105 

Income statement (P&L) ($ in millions)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues
(Revenue, Net)
2020 
Cost of revenue
(Cost of Goods and Services Sold)
(13)(13) 
Gross profit:87 
Operating expenses(8)(7) 
Operating income:00 
Nonoperating expense(0)(0) 
Investment income, nonoperating00 
Interest and debt expense(0)(0) 
Loss from continuing operations before equity method investments, income taxes:(0)(0) 
Other undisclosed income from continuing operations before income taxes00 
Income (loss) from continuing operations before income taxes:0(0) 
Income tax expense (benefit)(0)0 
Net loss available to common stockholders, diluted:(0)(0) 

Comprehensive Income ($ in millions)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net loss:(0)(0) 
Comprehensive loss:(0)(0) 
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)  
Comprehensive loss, net of tax, attributable to parent:(0)(0) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: